neobookRx
DrugsLevel 4 LocalisationS4INJEML

Lignocaine/ Adrenaline

CombinationAnalgesic

Indications

Registered South African indications:

  • Local anaesthetic
  • Dental extractions or operations

Cautions

Contraindications

  • Hypersensitivity to local anaesthetics of the amide type (e.g. lidocaine hydrochloride)
  • Patients with thyrotoxicosis
  • Cardiac disease, particularly those with arrhythmia or hypertension
  • Narrow-angle glaucoma
  • Patients with myasthenia gravis
  • Coadministration with tricyclic antidepressants

Cautions

  • Breastfeeding
  • Hepatic impairment
  • Intravenous administration
  • Epilepsy
  • Myasthenia gravis

Adult dosage

Forms avail. in SA and in this monograph: inj

Local anaesthetic
Dental extractions

  • Local infiltration: Dosage dependant on nature, magnitude and duration of procedure involved; Max: 7mg/kg

Paediatric dosage

See adult dosage

Special populations

Pregnancy

Breastfeeding

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Central Nervous System Disorders

  • Seizures 

Cardiovascular Disorders

  • Hypotension
  • Arrhythmias
  • Cardiovascular collapse

Respiratory Disorders 

  • Respiratory collapse

Gastrointestinal Disorders

  • Nausea and vomiting

Musculoskeletal Disorders

  • Muscle twitching

Interactions

  • Tricyclic antidepressants
  • Monoamine oxidase inhibitors
  • Alpha blockers
  • Beta blockers

Monitoring

None routine

Mechanism of action

Lignocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Lignocaine alters signal conduction in neurons by blocking the fast voltage gated sodium (Na+) channels in the neuronal cell membrane that are responsible for signal propagation. With sufficient blockage the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential. This creates the anaesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their birth in the first place.

Dosage forms

  • Injection

Formulation

COMBINATION PREPARATIONS

Lignocaine/ Adrenaline

Injection (per ml) 20mg/12.5μg

  • Xylotox E80-A  (Adcock Ingram) originator

References

1. PI: Xylotox E80-A Solution for Injection, Adcock Ingram Ltd:Date of registration: 2 Jul 1982 [https://drive.google.com/drive/u/0/folders/1prMse03xQI-j_2v1xk8Ko__o4X0jFLA0] 2. PI - XYLOTOX E80-A, Adcock Ingram Limited - DATE OF PUBLICATION OF THIS PACKAGE INSERT: 11 October 2013 Downloaded online 30 Sept 2024 [https://www.adcockingramrx.co.za/hcphub/handle-file?fileid=338]

Brands & products

3 products · cached snapshot
Trade names (1)
  • Xylotox E80-A

INJInjection· 3 products

from R274.32
ProductStrengthPackApplicantMin price
Xylestesin-A20 mg/ml;µg/ml503M South Africa (Pty) LtdR274.32
Lignospan 2%20 mg/ml;µg/ml1.8Henry Schein Dental Warehouse (Pty) LtdR511.27
Xylotox E80-A20 mg/ml;µg/ml1.8Adcock Ingram LimitedR1026.68

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 15433 · updated 9/30/2024